Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Elsner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pathologie (Heidelberg, Germany)|February 24, 2026
[Update on the regression grading of non-small cell lung cancer]Felix Elsner, Lena-Maria Löwer-Kiem, Florian Fuchs, et al.
Research Square|April 2, 2024
CD109 drives pro-tumorigenic cell properties in human non-small cell lung cancer through interaction with desmoglein-2Wiebke Lückstädt, Maitreyi Rathod, Lena Möbus, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2022
EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patientsTobias Mederer, Felix Elsner, Tobias Robold, et al.
International Journal of Molecular Sciences|March 14, 2026
GPS1 Exon 9 Mutations Represent a Rare Genetic Event in Penile Squamous Cell Carcinoma PathogenesisLars Tögel, Felix Elsner, Olaf Wendler, et al.
Archives of Pathology & Laboratory Medicine|December 12, 2025
Ultrastaging Confirms the Superior Sensitivity of Quantitative Immunocytology for Detection of Lymph Node Spread in Non-Small Cell Lung Cancer PatientsFelix Elsner, Jozef Zustin, Florian Weber, et al.
The Journal of Pathology|September 23, 2022
Disseminated cancer cells detected by immunocytology in lymph nodes of NSCLC patients are highly prognostic and undergo parallel molecular evolutionFelix Elsner, Martin Hoffmann, Rezan Fahrioglu-Yamaci, et al.
Histopathology|September 5, 2025
Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE studyFelix Elsner, Christiane Kümpers, German Ott, et al.
Communications Biology|May 13, 2025
TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse modelTabea Gewalt, Anna M Dmitrieva, Felix Elsner, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variabilityKonrad Steinestel, Lena-Maria Löwer-Kiem, Francesca Ambrosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic nicheLaura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pathologie (Heidelberg, Germany)|February 24, 2026
[Update on the regression grading of non-small cell lung cancer]Felix Elsner, Lena-Maria Löwer-Kiem, Florian Fuchs, et al.
Research Square|April 2, 2024
CD109 drives pro-tumorigenic cell properties in human non-small cell lung cancer through interaction with desmoglein-2Wiebke Lückstädt, Maitreyi Rathod, Lena Möbus, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2022
EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patientsTobias Mederer, Felix Elsner, Tobias Robold, et al.
International Journal of Molecular Sciences|March 14, 2026
GPS1 Exon 9 Mutations Represent a Rare Genetic Event in Penile Squamous Cell Carcinoma PathogenesisLars Tögel, Felix Elsner, Olaf Wendler, et al.
Archives of Pathology & Laboratory Medicine|December 12, 2025
Ultrastaging Confirms the Superior Sensitivity of Quantitative Immunocytology for Detection of Lymph Node Spread in Non-Small Cell Lung Cancer PatientsFelix Elsner, Jozef Zustin, Florian Weber, et al.
The Journal of Pathology|September 23, 2022
Disseminated cancer cells detected by immunocytology in lymph nodes of NSCLC patients are highly prognostic and undergo parallel molecular evolutionFelix Elsner, Martin Hoffmann, Rezan Fahrioglu-Yamaci, et al.
Histopathology|September 5, 2025
Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE studyFelix Elsner, Christiane Kümpers, German Ott, et al.
Communications Biology|May 13, 2025
TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse modelTabea Gewalt, Anna M Dmitrieva, Felix Elsner, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variabilityKonrad Steinestel, Lena-Maria Löwer-Kiem, Francesca Ambrosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic nicheLaura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl, et al.
Pageof 1